ChromaDex Shares Findings from First Clinical Study on Nicotinamide Riboside (NR) in Children, Highlighting Improvements for Prematurely Aging Patients with Ataxia-Telangiectasia (AT)
Stock Information for ChromaDex Corporation
Loading
Please wait while we load your information from QuoteMedia.